Medical Communications

Showing 15 posts of 6408 posts found.

pills_in_hand

NICE urges curbing the use of antibiotics for sore throats

January 26, 2018 Medical Communications Antibiotics, NICE, biotech, drugs, pharma, pharmaceutical

In a study published by the BMJ a few years ago, it was found that antibiotics were prescribed in 60% …

AZ’s triple therapy inhaler hits 8 out of 9 endpoints

January 26, 2018 Medical Communications, Research and Development AstraZeneca, COPD, biotech, drugs, pharma, pharmaceutical

AstraZeneca has made a brief announcement that its triple therapy inhaler manage to successfully hit eight of nine primary endpoints …

iQOS heat-not-burn electronic tobacco product doesn’t reduce health risk, FDA says

January 26, 2018 Medical Communications, Sales and Marketing FDA, Philip Morris, iQOS, pharma, smoking, tobacco

An advisory panel of the FDA has judged that US tobacco firm Philip Morris International (PMI) has not been able …

Biogen announces acquisition along with financials, but it’s tiny

January 26, 2018 Medical Communications, Sales and Marketing Biogen, Karyopharm, biotech, drugs, pharma, pharmaceutical

Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big …
alex_azar_wwsg_photo_cropped

Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate

January 25, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …
nicolas_raymond

The measurement underpinning government goals for UK life sciences

January 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Industrial Strategy, brexit, john bell, life sciences, pharma

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …
epilim

20,000 left disabled in UK due to sodium valproate use during pregnancy

January 22, 2018 Medical Communications, Sales and Marketing Epilim, Sanofi, Sodium valproate, UK, pharma

Liberal Democrat MP Norman Lamb has drawn attention to what he has called an “extraordinary scandal” in which an estimated …
astrazeneca_sign_sky

AstraZeneca scores double approvals in Japan for asthma and ovarian cancer

January 19, 2018 Medical Communications, Sales and Marketing AstraZeneca, Cancer, Fasenra, Japan, asthma, lynparza, ovarian cancer, pharma

AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra (benralizumab) has been given authorisation …
sandoz

Novartis enters biosimilar agreement with Biocon

January 19, 2018 Medical Communications, Sales and Marketing Biocon, Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and …
pfizer-building-logo1web

Pfizer’s Xalkori sees rejection at the hands of NICE in lung cancer

January 19, 2018 Medical Communications, Sales and Marketing Cancer, NCIE, NSCLC, Pfizer, UK, Xalkori, lung cancer, pharma

UK regulator NICE has announced its decision not to recommend Pfizer’s Xalkori (crizotinib) for use on the NHS in the …
gilead-sciences

Gilead aims to claim edge with Pfizer CAR-T combo

January 18, 2018 Medical Communications, Research and Development Gilead, Kite, Yescarta, biotech, drugs, pharma, pharmaceutical

Although those in pharma often dislike any references to drugs competing with each other for market as in a ‘race’, …
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …
darzalex

NICE meets Janssen halfway over Darzalex

January 18, 2018 Medical Communications, Sales and Marketing J&J, JJ, Janssen, biotech, darzalex, drugs, pharma, pharmaceutical

NICE rejected Janssen’s Darzalex (Daratumumab) back in March last year, concluding that it wasn’t able to accurately determine the efficacy …
blood-20745_960_720

Research calls for BRCA testing in all women

January 18, 2018 Medical Communications, Research and Development BRCA, biotech, drugs, pharma, pharmaceutical

For women, possessing a mutated BRCA1 or BRCA2 gene significantly increases the chances of developing breast or ovarian cancer; at …
The Gateway to Local Adoption Series

Latest content